Comparison of the outcome of limited protocol Ranibizumab injection in naïve choroidal neovascular membranes secondary to pathological myopia versus age-related macular degeneration-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparison of the outcome of limited protocol Ranibizumab injection in naïve choroidal neovascular membranes secondary to pathological myopia versus age-related macular degeneration

Published:2023 Issue:2 Volume:116 Page:99
ISSN:2090-0686
Container-title:Journal of the Egyptian Ophthalmological Society
language:en
Short-container-title:J Egypt Ophthalmol Soc

Author:

Fawzy SamahM,Al-Tawab MohammedS.A,Ismail ZaferF,Ebeid WeamM.A

Publisher

Medknow

Subject

General Medicine

Reference31 articles.

1. Semaphorin 3A blocks the formation of pathologic choroidal neovascularization induced by transforming growth factor beta;Bai;Mol Vis,2014

2. Clinical and differential utility of VEGF inhibitors in wet age-related macular degeneration: focus on aflibercept;Stewart;Clin Ophthalmol,2012

3. Ranibizumab for the treatment of wet AMD: a summary of real-world studies;Chong;Eye,2016

4. Anti-vascular endothelial growth factor for choroidal neovascularization in pathologic myopia;Battaglia;Dev Ophthalmol,2010

5. Ranibizumab for the treatment of choroidal neovascularisation secondary to pathological myopia: interim analysis of the REPAIR study;Tufail;Eye,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP